Skip to main content
. 2018 Mar 14;2018:2601945. doi: 10.1155/2018/2601945

Figure 4.

Figure 4

In vivo assessment of the immunomodulatory properties of miPSC-MSC in a sponge model of periodontitis. (a) Representative light microscopy images of H&E stained sections of the implanted sponges 14 days after the injection of PBS, or 5 × 106 miPSC-MSC via tail vein injection (IV) or subcutaneous injection (SC). (b) Semiquantitative scoring of the level of immune cell infiltrate present in histological slides of the implanted sponges (∗p value <0.05 as determined by one-way ANOVA with multiple comparisons, n = 6).